| class name | count |
|---|---|
| rosids | 2 |
| class name | count |
|---|---|
| Fabaceae | 2 |
| br08003 Category | # of metabolite |
|---|
| br08003 Category | KEGG ID | KNApSAcK ID |
|---|
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
|---|---|---|---|---|---|---|
|
C00042226
|
Amphetamine
|
CHEMBL405
CHEMBL19393 CHEMBL612 |
D000661
|
10 / 7 / 4 | 32 / 144 |
|
|
C00042732
|
Methamphetamine
/ (+)-Methamphetamine |
CHEMBL1201201
CHEMBL1927030 |
D008694
|
8 / 4 / 5 | 95 / 172 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| O76082 | Solute carrier family 22 member 5 | Unclassified protein | C00042226 C00042732 | 1 / 2 |
| Q96RJ0 | Trace amine-associated receptor 1 | Trace amine receptor | C00042226 C00042732 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00042226 C00042732 | 1 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00042226 | 1 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00042732 | 0 / 1 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00042226 | 0 / 0 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00042226 | 0 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00042226 | 1 / 1 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00042226 | 2 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00042732 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00042732 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00042732 | 0 / 1 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00042226 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00042226 | 1 / 1 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00042732 | 1 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 135 | ADORA2A, A2aR, ADORA2, RDC8 | adenosine A2a receptor |
C00042226
C00042732
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00042226
C00042732
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00042226
C00042732
|
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00042226
C00042732
|
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00042226
C00042732
|
| 6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00042226
C00042732
|
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00042226
C00042732
|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00042226
C00042732
|
| 1813 | DRD2, D2DR, D2R | dopamine receptor D2 |
C00042226
C00042732
|
| 6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00042226
C00042732
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00042226
C00042732
|
| 2566 | GABRG2, CAE2, ECA2, GEFSP3 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
C00042226
C00042732
|
| 2554 | GABRA1, ECA4, EJM, EJM5 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
C00042226
C00042732
|
| 9568 | GABBR2, GABABR2, GPR51, GPRC3B, HG20, HRIHFB2099 | gamma-aminobutyric acid (GABA) B receptor, 2 |
C00042226
C00042732
|
| 9463 | PICK1, PICK, PRKCABP | protein interacting with PRKCA 1 |
C00042732
|
| 2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00042226
|
| 2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B |
C00042226
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00042226
|
| 2166 | FAAH, FAAH-1, PSAB | fatty acid amide hydrolase (EC:3.5.1.99) |
C00042226
|
| 2670 | GFAP | glial fibrillary acidic protein |
C00042226
|
| 692548 |
C00042226
|
||
| 2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00042226
|
| 3726 | JUNB, AP-1 | jun B proto-oncogene |
C00042226
|
| 3727 | JUND, AP-1 | jun D proto-oncogene |
C00042226
|
| 4129 | MAOB | monoamine oxidase B (EC:1.4.3.4) |
C00042226
|
| 8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00042226
|
| 5179 | PENK | proenkephalin |
C00042226
|
| 2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) |
C00042226
|
| 1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00042226
|
| 1454 | CSNK1E, CKIepsilon, HCKIE | casein kinase 1, epsilon (EC:2.7.11.1) |
C00042226
|
| 7035 | TFPI, EPI, LACI, TFI, TFPI1 | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
C00042226
|
| 250 | ALPP, ALP, PALP, PLAP, PLAP-1 | alkaline phosphatase, placental (EC:3.1.3.1) |
C00042226
|
| 23305 | ACSL6, ACS2, FACL6, LACS_6, LACS2, LACS5 | acyl-CoA synthetase long-chain family member 6 (EC:6.2.1.3) |
C00042732
|
| 26289 | AK5, AK6 | adenylate kinase 5 (EC:2.7.4.3 2.7.4.6) |
C00042732
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00042732
|
| 313 | AOAH | acyloxyacyl hydrolase (neutrophil) (EC:3.1.1.77) |
C00042732
|
| 409 | ARRB2, ARB2, ARR2, BARR2 | arrestin, beta 2 |
C00042732
|
| 23245 | ASTN2, bA67K19.1 | astrotactin 2 |
C00042732
|
| 627 | BDNF, ANON2, BULN2 | brain-derived neurotrophic factor |
C00042732
|
| 54535 | CCHCR1, C6orf18, HCR, SBP | coiled-coil alpha-helical rod protein 1 |
C00042732
|
| 1604 | CD55, CR, CROM, DAF, TC | CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
C00042732
|
| 1012 | CDH13, CDHH, P105 | cadherin 13 (EC:3.6.1.3) |
C00042732
|
| 1061 |
C00042732
|
||
| 1103 | CHAT, CHOACTASE, CMS1A, CMS1A2 | choline O-acetyltransferase (EC:2.3.1.6) |
C00042732
|
| 340267 | COL28A1, COL28 | collagen, type XXVIII, alpha 1 |
C00042732
|
| 1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00042732
|
| 64478 | CSMD1, PPP1R24 | CUB and Sushi multiple domains 1 |
C00042732
|
| 8029 | CUBN, IFCR, MGA1, gp280 | cubilin (intrinsic factor-cobalamin receptor) |
C00042732
|
| 171522 |
C00042732
|
||
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00042732
|
| 81501 | DCSTAMP, FIND, TM7SF4, hDC-STAMP | dendrocyte expressed seven transmembrane protein |
C00042732
|
| 1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00042732
|
| 1814 | DRD3, D3DR, ETM1, FET1 | dopamine receptor D3 |
C00042732
|
| 1815 | DRD4, D4DR | dopamine receptor D4 |
C00042732
|
| 1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00042732
|
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00042732
|
| 2272 | FHIT, AP3Aase, FRA3B | fragile histidine triad (EC:3.6.1.29) |
C00042732
|
| 23307 | FKBP15, FKBP133, KIAA0674, PPP1R76 | FK506 binding protein 15, 133kDa (EC:5.2.1.8) |
C00042732
|
| 2912 | GRM2, GLUR2, GPRC1B, MGLUR2, mGlu2 | glutamate receptor, metabotropic 2 |
C00042732
|
| 2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00042732
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00042732
|
| 2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00042732
|
| 9951 | HS3ST4, 3-OST-4, 30ST4, 3OST4, h3-OST-4 | heparan sulfate (glucosamine) 3-O-sulfotransferase 4 (EC:2.8.2.23) |
C00042732
|
| 3350 | HTR1A, 5-HT-1A, 5-HT1A, 5HT1a, ADRB2RL1, ADRBRL1, G-21, PFMCD | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
C00042732
|
| 3362 | HTR6, 5-HT6, 5-HT6R | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
C00042732
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00042732
|
| 9215 | LARGE, MDC1D, MDDGA6, MDDGB6 | like-glycosyltransferase |
C00042732
|
| 158038 | LINGO2, LERN3, LRRN6C | leucine rich repeat and Ig domain containing 2 |
C00042732
|
| 5607 | MAP2K5, HsT17454, MAPKK5, MEK5, PRKMK5 | mitogen-activated protein kinase kinase 5 (EC:2.7.12.2) |
C00042732
|
| 64757 | MARC1, MOSC1 | mitochondrial amidoxime reducing component 1 |
C00042732
|
| 54996 | MARC2, MOSC2, RP11-270A6.1 | mitochondrial amidoxime reducing component 2 |
C00042732
|
| 4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00042732
|
| 4502 | MT2A, MT2 | metallothionein 2A |
C00042732
|
| 2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00042732
|
| 4645 | MYO5B | myosin VB |
C00042732
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00042732
|
| 4886 | NPY1R, NPY1-R, NPYR | neuropeptide Y receptor Y1 |
C00042732
|
| 3084 | NRG1, ARIA, GGF, GGF2, HGL, HRG, HRG1, HRGA, MST131, NDF, SMDF | neuregulin 1 |
C00042732
|
| 4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00042732
|
| 26577 | PCOLCE2, PCPE2 | procollagen C-endopeptidase enhancer 2 |
C00042732
|
| 5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00042732
|
| 5144 | PDE4D, ACRDYS2, DPDE3, HSPDE4D, PDE43, PDE4DN2, STRK1 | phosphodiesterase 4D, cAMP-specific (EC:3.1.4.17) |
C00042732
|
| 5146 | PDE6C, ACHM5, COD4, PDEA2 | phosphodiesterase 6C, cGMP-specific, cone, alpha prime (EC:3.1.4.35) |
C00042732
|
| 5173 | PDYN, ADCA, PENKB, SCA23 | prodynorphin |
C00042732
|
| 8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00042226
|
| 5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00042732
|
| 7799 | PRDM2, HUMHOXY1, KMT8, MTB-ZF, RIZ, RIZ1, RIZ2 | PR domain containing 2, with ZNF domain (EC:2.1.1.43) |
C00042732
|
| 5592 | PRKG1, 1, AAT8, PKG, PRKG1B, PRKGR1B, cGK, cGK_1, cGK1, cGKI, cGKI-BETA, cGKI-alpha | protein kinase, cGMP-dependent, type I (EC:2.7.11.12) |
C00042732
|
| 5617 | PRL | prolactin |
C00042732
|
| 128674 | PROKR2, GPR73L1, GPR73b, GPRg2, HH3, KAL3, PKR2, dJ680N4.3 | prokineticin receptor 2 |
C00042732
|
| 23362 | PSD3, EFA6R, HCA67 | pleckstrin and Sec7 domain containing 3 |
C00042732
|
| 5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00042732
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00042732
|
| 22913 | RALY, HNRPCL2, P542 | RALY heterogeneous nuclear ribonucleoprotein |
C00042732
|
| 9771 | RAPGEF5, GFR, MR-GEF, REPAC | Rap guanine nucleotide exchange factor (GEF) 5 |
C00042732
|
| 26575 | RGS17, RGS-17, RGSZ2, hRGS17 | regulator of G-protein signaling 17 |
C00042732
|
| 5104 | SERPINA5, PAI-3, PAI3, PCI, PCI-B, PLANH3, PROCI | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
C00042732
|
| 137868 | SGCZ, ZSG1 | sarcoglycan, zeta |
C00042732
|
| 344558 | SH3RF3, POSH2, SH3MD4 | SH3 domain containing ring finger 3 |
C00042732
|
| 6571 | SLC18A2, SVAT, SVMT, VAT2, VMAT2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
C00042732
|
| 6518 | SLC2A5, GLUT-5, GLUT5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
C00042732
|
| 6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00042732
|
| 6536 | SLC6A9, GLYT1 | solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
C00042732
|
| 64754 | SMYD3, KMT3E, ZMYND1, ZNFN3A1, bA74P14.1 | SET and MYND domain containing 3 (EC:2.1.1.43) |
C00042732
|
| 6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00042732
|
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00042732
|
| 6855 | SYP, MRXSYP | synaptophysin |
C00042732
|
| 134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00042732
|
| 7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00042732
|
| 7137 | TNNI3, CMD1FF, CMD2A, CMH7, RCM1, TNNC1, cTnI | troponin I type 3 (cardiac) |
C00042732
|
| 80036 | TRPM3, GON-2, LTRPC3, MLSN2 | transient receptor potential cation channel, subfamily M, member 3 |
C00042732
|
| 84196 | USP48, RAP1GA1, USP31 | ubiquitin specific peptidase 48 (EC:3.4.19.12) |
C00042732
|
| 79750 | ZNF385D, ZNF659 | zinc finger protein 385D |
C00042732
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #103780 | Alcohol dependence |
P31645
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300615 | Brunner syndrome |
P21397
|
| #212140 | Carnitine deficiency, systemic primary; cdsp |
O76082
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| KEGG | name | UniProt |
|---|---|---|
| H00286 | Crohn's disease |
O76082
(related)
|
| H00525 | Disorders of fatty-acid oxidation |
O76082
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D015746 | Abdominal Pain |
C00042226
C00042732 |
| D000014 | Abnormalities, Drug-Induced |
C00042226
C00042732 |
| D054058 | Acute Coronary Syndrome |
C00042226
C00042732 |
| D015431 | Weight Loss |
C00042226
C00042732 |
| D014839 | Vomiting |
C00042226
C00042732 |
| D019969 | Amphetamine-Related Disorders |
C00042226
C00042732 |
| D018487 | Ventricular Dysfunction, Left |
C00042226
C00042732 |
| D020301 | Vasospasm, Intracranial |
C00042226
C00042732 |
| D000784 | Aneurysm, Dissecting |
C00042226
C00042732 |
| D017542 | Aneurysm, Ruptured |
C00042226
C00042732 |
| D000855 | Anorexia |
C00042226
C00042732 |
| D020293 | Vasculitis, Central Nervous System |
C00042226
C00042732 |
| D001008 | Anxiety Disorders |
C00042226
C00042732 |
| D014657 | Vasculitis |
C00042226
C00042732 |
| D001145 | Arrhythmias, Cardiac |
C00042226
C00042732 |
| D016055 | Urinary Retention |
C00042226
C00042732 |
| D013610 | Tachycardia |
C00042226
C00042732 |
| D001289 | Attention Deficit Disorder with Hyperactivity |
C00042226
C00042732 |
| D013375 | Substance Withdrawal Syndrome |
C00042226
C00042732 |
| D019966 | Substance-Related Disorders |
C00042226
C00042732 |
| D013345 | Subarachnoid Hemorrhage |
C00042226
C00042732 |
| D001925 | Brain Damage, Chronic |
C00042226
C00042732 |
| D001927 | Brain Diseases |
C00042226
C00042732 |
| D020521 | Stroke |
C00042226
C00042732 |
| D002545 | Brain Ischemia |
C00042226
C00042732 |
| D002012 | Bruxism |
C00042226
C00042732 |
| D019956 | Stereotypic Movement Disorder |
C00042226
C00042732 |
| D009202 | Cardiomyopathies |
C00042226
C00042732 |
| D002311 | Cardiomyopathy, Dilated |
C00042226
C00042732 |
| D013226 | Status Epilepticus |
C00042226
C00042732 |
| D012640 | Seizures |
C00042226
C00042732 |
| D002543 | Cerebral Hemorrhage |
C00042226
C00042732 |
| D002544 | Cerebral Infarction |
C00042226
C00042732 |
| D002637 | Chest Pain |
C00042226
C00042732 |
| D012559 | Schizophrenia |
C00042226
C00042732 |
| D002819 | Chorea |
C00042226
C00042732 |
| D012206 | Rhabdomyolysis |
C00042226
C00042732 |
| D019970 | Cocaine-Related Disorders |
C00042226
C00042732 |
| D003072 | Cognition Disorders |
C00042226
C00042732 |
| D017091 | Colitis, Ischemic |
C00042226
C00042732 |
| D011654 | Pulmonary Edema |
C00042226
C00042732 |
| D003329 | Coronary Vasospasm |
C00042226
C00042732 |
| D016757 | Death, Sudden, Cardiac |
C00042226
C00042732 |
| D003866 | Depressive Disorder |
C00042226
C00042732 |
| C536282 | Pulmonary arterial hypertension |
C00042226
C00042732 |
| D011618 | Psychotic Disorders |
C00042226
C00042732 |
| D004211 | Disseminated Intravascular Coagulation |
C00042226
C00042732 |
| D011605 | Psychoses, Substance-Induced |
C00042226
C00042732 |
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00042226
C00042732 |
| D004409 | Dyskinesia, Drug-Induced |
C00042226
C00042732 |
| D011595 | Psychomotor Agitation |
C00042226
C00042732 |
| D011297 | Prenatal Exposure Delayed Effects |
C00042226
C00042732 |
| D010300 | Parkinson Disease |
C00042226
C00042732 |
| D010259 | Paranoid Disorders |
C00042226
C00042732 |
| D009422 | Nervous System Diseases |
C00042226
C00042732 |
| D009410 | Nerve Degeneration |
C00042226
C00042732 |
| D009290 | Narcolepsy |
C00042226
C00042732 |
| D009212 | Myoglobinuria |
C00042226
C00042732 |
| D017202 | Myocardial Ischemia |
C00042226
C00042732 |
| D009203 | Myocardial Infarction |
C00042226
C00042732 |
| D009069 | Movement Disorders |
C00042226
C00042732 |
| D005334 | Fever |
C00042226
C00042732 |
| D005911 | Gliosis |
C00042226
C00042732 |
| D006130 | Growth Disorders |
C00042226
C00042732 |
| D006212 | Hallucinations |
C00042226
C00042732 |
| D001523 | Mental Disorders |
C00042226
C00042732 |
| D008569 | Memory Disorders |
C00042226
C00042732 |
| D007859 | Learning Disorders |
C00042226
C00042732 |
| D020300 | Intracranial Hemorrhages |
C00042226
C00042732 |
| D015658 | HIV Infections |
C00042226
C00042732 |
| D007174 | Impulse Control Disorders |
C00042226
C00042732 |
| D006930 | Hyperalgesia |
C00042226
C00042732 |
| D006948 | Hyperkinesis |
C00042226
C00042732 |
| D006973 | Hypertension |
C00042226
C00042732 |
| D006976 | Hypertension, Pulmonary |
C00042226
C00042732 |
| D007035 | Hypothermia |
C00042226
C00042732 |
| D010468 | Perceptual Disorders |
C00042732
|
| D018476 | Hypokinesia |
C00042226
|
| D020896 | Hypovolemia |
C00042226
|
| D016142 | Holoprosencephaly |
C00042226
|
| D020244 | Infarction, Middle Cerebral Artery |
C00042226
|
| D002532 | Intracranial Aneurysm |
C00042226
|
| D002542 | Intracranial Embolism and Thrombosis |
C00042226
|
| D006556 | Heroin Dependence |
C00042226
|
| D007673 | Kidney Cortex Necrosis |
C00042226
|
| D046649 | Hematoma, Subdural, Spinal |
C00042226
|
| D008107 | Liver Diseases |
C00042226
|
| D006341 | Heart Rupture |
C00042226
|
| D034381 | Hearing Loss |
C00042226
|
| D005221 | Fatigue |
C00042226
|
| D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00042226
|
| D004827 | Epilepsy |
C00042226
|
| D009205 | Myocarditis |
C00042226
|
| D004831 | Epilepsies, Myoclonic |
C00042226
|
| D004681 | Encephalomyelitis, Autoimmune, Experimental |
C00042226
|
| D009369 | Neoplasms |
C00042226
|
| D009395 | Nephritis, Interstitial |
C00042226
|
| D004438 | Ecchymosis |
C00042226
|
| D001068 | Eating Disorders |
C00042226
|
| D019150 | Neuroaxonal Dystrophies |
C00042226
|
| D019636 | Neurodegenerative Diseases |
C00042226
|
| D009459 | Neuroleptic Malignant Syndrome |
C00042226
|
| D010146 | Pain |
C00042226
|
| D004421 | Dystonia |
C00042226
|
| D010291 | Paresis |
C00042226
|
| D019263 | Dysthymic Disorder |
C00042226
|
| D010493 | Pericarditis |
C00042226
|
| D010554 | Personality Disorders |
C00042226
|
| D017689 | Polydactyly |
C00042226
|
| D011230 | Precancerous Conditions |
C00042226
|
| D011248 | Pregnancy Complications |
C00042226
|
| D047928 | Premature Birth |
C00042226
|
| D004417 | Dyspnea |
C00042226
|
| D011317 | Priapism |
C00042226
|
| D020820 | Dyskinesias |
C00042226
|
| D062787 | Drug Overdose |
C00042226
|
| D004195 | Disease Models, Animal |
C00042226
|
| D002658 | Developmental Disabilities |
C00042226
|
| D003323 | Coronary Aneurysm |
C00042226
|
| D011693 | Purpura |
C00042226
|
| D011782 | Quadriplegia |
C00042226
|
| D012128 | Respiratory Distress Syndrome, Adult |
C00042226
|
| C535485 | Chromosome 13q trisomy |
C00042226
|
| D002653 | Child Behavior Disorders |
C00042226
|
| D002385 | Cataplexy |
C00042226
|
| D012652 | Self Mutilation |
C00042226
|
| D020018 | Sexual Dysfunctions, Psychological |
C00042226
|
| D012893 | Sleep Disorders |
C00042226
|
| D002340 | Carotid Artery Diseases |
C00042226
|
| D006502 | Budd-Chiari Syndrome |
C00042226
|
| D001930 | Brain Injuries |
C00042226
|
| D053608 | Stupor |
C00042226
|
| D001919 | Bradycardia |
C00042226
|
| D001832 | Body Temperature Changes |
C00042226
|
| D001714 | Bipolar Disorder |
C00042226
|
| D001284 | Atrophy |
C00042226
|
| D054549 | Takotsubo Cardiomyopathy |
C00042226
|
| D001167 | Arteritis |
C00042226
|
| D017545 | Aortic Aneurysm, Thoracic |
C00042226
|
| D056988 | Anterior Wall Myocardial Infarction |
C00042226
|
| D000783 | Aneurysm |
C00042226
|
| D000740 | Anemia |
C00042226
|
| D000647 | Amnesia |
C00042226
|
| D058186 | Acute Kidney Injury |
C00042226
|
| D000037 | Abruptio Placentae |
C00042732
|
| D000379 | Agoraphobia |
C00042732
|
| D015526 | AIDS Dementia Complex |
C00042732
|
| D000437 | Alcoholism |
C00042732
|
| D000789 | Angina, Unstable |
C00042732
|
| D050197 | Atherosclerosis |
C00042732
|
| D001264 | Athetosis |
C00042732
|
| D054537 | Atrioventricular Block |
C00042732
|
| D053099 | Azotemia |
C00042732
|
| D001480 | Basal Ganglia Diseases |
C00042732
|
| D006332 | Cardiomegaly |
C00042732
|
| D002318 | Cardiovascular Diseases |
C00042732
|
| D002375 | Catalepsy |
C00042732
|
| D002386 | Cataract |
C00042732
|
| D002493 | Central Nervous System Diseases |
C00042732
|
| D002561 | Cerebrovascular Disorders |
C00042732
|
| D023341 | Chills |
C00042732
|
| D002779 | Cholestasis |
C00042732
|
| D019955 | Conduct Disorder |
C00042732
|
| D003244 | Consciousness Disorders |
C00042732
|
| D003320 | Corneal Ulcer |
C00042732
|
| D003693 | Delirium |
C00042732
|
| D003731 | Dental Caries |
C00042732
|
| D003865 | Depressive Disorder, Major |
C00042732
|
| D004244 | Dizziness |
C00042732
|
| D004342 | Drug Hypersensitivity |
C00042732
|
| D004401 | Dysarthria |
C00042732
|
| D004487 | Edema |
C00042732
|
| D009877 | Endophthalmitis |
C00042732
|
| D004802 | Eosinophilia |
C00042732
|
| D004830 | Epilepsy, Tonic-Clonic |
C00042732
|
| D005317 | Fetal Growth Retardation |
C00042732
|
| D020233 | Gait Disorders, Neurologic |
C00042732
|
| D005767 | Gastrointestinal Diseases |
C00042732
|
| D006261 | Headache |
C00042732
|
| D006331 | Heart Diseases |
C00042732
|
| D006333 | Heart Failure |
C00042732
|
| D006606 | Hiccup |
C00042732
|
| D006967 | Hypersensitivity |
C00042732
|
| D006984 | Hypertrophy |
C00042732
|
| D017379 | Hypertrophy, Left Ventricular |
C00042732
|
| D007154 | Immune System Diseases |
C00042732
|
| D007676 | Kidney Failure, Chronic |
C00042732
|
| D007683 | Kidney Tubular Necrosis, Acute |
C00042732
|
| D056784 | Leukoencephalopathies |
C00042732
|
| D017114 | Liver Failure, Acute |
C00042732
|
| D008171 | Lung Diseases |
C00042732
|
| D020422 | Mononeuropathies |
C00042732
|
| D019964 | Mood Disorders |
C00042732
|
| D016472 | Motor Neuron Disease |
C00042732
|
| D019957 | Motor Skills Disorders |
C00042732
|
| D009059 | Mouth Diseases |
C00042732
|
| D009127 | Muscle Rigidity |
C00042732
|
| D009325 | Nausea |
C00042732
|
| D009336 | Necrosis |
C00042732
|
| D019954 | Neurobehavioral Manifestations |
C00042732
|
| D020258 | Neurotoxicity Syndromes |
C00042732
|
| D009771 | Obsessive-Compulsive Disorder |
C00042732
|
| D009784 | Occupational Diseases |
C00042732
|
| D009901 | Optic Nerve Diseases |
C00042732
|
| D010024 | Osteoporosis |
C00042732
|
| D016584 | Panic Disorder |
C00042732
|
| D010202 | Panophthalmitis |
C00042732
|
| D010254 | Paranasal Sinus Diseases |
C00042732
|
| D010292 | Paresthesia |
C00042732
|
| D010302 | Parkinson Disease, Secondary |
C00042732
|
| D007022 | Hypotension |
C00042226
|
| D016491 | Peripheral Vascular Diseases |
C00042732
|
| D011041 | Poisoning |
C00042732
|
| D049188 | Prenatal Injuries |
C00042732
|
| D011596 | Psychomotor Disorders |
C00042732
|
| D051437 | Renal Insufficiency |
C00042732
|
| D012140 | Respiratory Tract Diseases |
C00042732
|
| D012164 | Retinal Diseases |
C00042732
|
| D015423 | Scleritis |
C00042732
|
| D012749 | Sexually Transmitted Diseases |
C00042732
|
| D012769 | Shock |
C00042732
|
| D012770 | Shock, Cardiogenic |
C00042732
|
| D012871 | Skin Diseases |
C00042732
|
| D007319 | Sleep Initiation and Maintenance Disorders |
C00042732
|
| D018461 | Soft Tissue Infections |
C00042732
|
| D013064 | Speech Disorders |
C00042732
|
| D013207 | Staphylococcal Skin Infections |
C00042732
|
| D015819 | Substance Abuse, Intravenous |
C00042732
|
| D013587 | Syphilis |
C00042732
|
| D013617 | Tachycardia, Supraventricular |
C00042732
|
| D017180 | Tachycardia, Ventricular |
C00042732
|
| D013706 | Temporomandibular Joint Dysfunction Syndrome |
C00042732
|
| D014076 | Tooth Diseases |
C00042732
|
| D014202 | Tremor |
C00042732
|
| D014313 | Trismus |
C00042732
|
| D018754 | Ventricular Dysfunction |
C00042732
|
| D014693 | Ventricular Fibrillation |
C00042732
|
| D018879 | Ventricular Premature Complexes |
C00042732
|
| D014786 | Vision Disorders |
C00042732
|
| D014987 | Xerostomia |
C00042732
|